Budget Impact Analysis of Belumosudil for Chronic Graft-Versus-Host Disease Treatment in the United States

被引：0
|
作者：
Bachier, Carlos [1 ]
Skaar, Jeffrey Rolf [2 ]
Dehipawala, Sumudu [2 ]
Miao, Benjamin [3 ]
Ieyoub, Jonathan [4 ]
Taite, Haya [4 ]
机构：
[1] Methodist Hosp, Sarah Cannon Transplant & Cellular Therapy Progra, San Antonio, TX USA
[2] Trin Life Sci, New York, NY USA
[3] Trin Life Sci, Princeton, NJ USA
[4] Kadmon Corp, New York, NY USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-146839
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1903
引用
收藏
页码：1903 / +
页数：4
相关论文
共 50 条
  • [1] Budget impact analysis of belumosudil for chronic graft-versus-host disease treatment in the United States
    Bachier, Carlos R.
    Skaar, Jeffrey R.
    Dehipawala, Sumudu
    Miao, Benjamin
    Ieyoub, Jonathan
    Taitel, Haya
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 857 - 863
  • [2] Belumosudil for chronic graft-versus-host disease
    Taylor, Breanna
    Cohen, Jaimie
    Tejeda, Jennifer
    Wang, Trent Peng
    DRUGS OF TODAY, 2022, 58 (05) : 203 - 212
  • [3] Combination treatment of extracorporeal photopheresis and belumosudil for chronic graft-versus-host disease
    Swallow, Madisen A.
    Chang, Jungsoo
    Carlson, Kacie R.
    Odell, Ian
    Girardi, Michael
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [4] Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease
    Pusic, Iskra
    Lee, Catherine
    Veeraputhiran, Muthu
    Minor, Chelsea
    Dipersio, John F.
    BONE MARROW TRANSPLANTATION, 2024, 59 (02) : 282 - 284
  • [5] Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease
    Iskra Pusic
    Catherine Lee
    Muthu Veeraputhiran
    Chelsea Minor
    John F. DiPersio
    Bone Marrow Transplantation, 2024, 59 : 282 - 284
  • [6] Clinical efficacy of belumosudil in cutaneous chronic graft-versus-host disease
    Petty, A. J.
    Glennon, C.
    Fixsen, E.
    Cardones, A.
    Whitley, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S160 - S160
  • [7] Belumosudil Combination Therapy in Refractory Chronic Graft-Versus-Host Disease
    Chin, Michelle
    Shizuru, Judith A.
    Muffly, Lori
    Shiraz, Parveen
    Johnston, Laura J.
    Lowsky, Robert
    Rezvani, Andrew R.
    Frank, Matthew J.
    Bharadwaj, Sushma
    Weng, Wen-Kai
    Negrin, Robert S.
    Miklos, David B.
    Arai, Sally
    BLOOD, 2022, 140 : 4788 - 4789
  • [8] Belumosudil Impacts Immunosuppression Pharmacokinetics in Patients with Chronic Graft-Versus-Host Disease
    Gaskill, Eric
    Padilla, Maya
    Faramand, Rawan
    Lazaryan, Aleksandr
    Khimani, Farhad
    Perez, Lia
    Pidala, Joseph
    Gonzalez, Rebecca
    BLOOD, 2022, 140 : 10512 - 10513
  • [9] Belumosudil Impacts Immunosuppression Pharmacokinetics in Patients with Chronic Graft-versus-Host Disease
    Gonzalez, Rebecca
    Gaskill, Eric
    Padilla, Maya
    Pidala, Joseph
    Lazaryan, Aleksandr
    Perez, Lia
    Khimani, Farhad
    Faramand, Rawan
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (09): : 577.e1 - 577.e9
  • [10] Belumosudil for the treatment of chronic graft-versus-host disease: a single center real-world experience
    Modi, Badri
    Ngo, Dat
    Chen, Jason
    Yang, Dongyun
    Shan, Haoyue
    Sandhu, Karamjeet
    Rashid, Nahid
    Amanam, Idoroenyi
    Otoukesh, Salman
    Nakamura, Ryotaro
    Ali, Haris
    Salhotra, Amandeep
    BONE MARROW TRANSPLANTATION, 2025, 60 (04) : 555 - 557
12345